• Education
    • Higher Education
    • Scholarships & Grants
    • Online Learning
    • School Reforms
    • Research & Innovation
  • Lifestyle
    • Travel
    • Food & Drink
    • Fashion & Beauty
    • Home & Living
    • Relationships & Family
  • Technology & Startups
    • Software & Apps
    • Startup Success Stories
    • Startups & Innovations
    • Tech Regulations
    • Venture Capital
    • Artificial Intelligence
    • Cybersecurity
    • Emerging Technologies
    • Gadgets & Devices
    • Industry Analysis
  • About us
  • Contact
  • Advertise with Us
  • Privacy & Policy
Today Headline
  • Home
  • World News
    • Us & Canada
    • Europe
    • Asia
    • Africa
    • Middle East
  • Politics
    • Elections
    • Political Parties
    • Government Policies
    • International Relations
    • Legislative News
  • Business & Finance
    • Market Trends
    • Stock Market
    • Entrepreneurship
    • Corporate News
    • Economic Policies
  • Science & Environment
    • Space Exploration
    • Climate Change
    • Wildlife & Conservation
    • Environmental Policies
    • Medical Research
  • Health
    • Public Health
    • Mental Health
    • Medical Breakthroughs
    • Fitness & Nutrition
    • Pandemic Updates
  • Sports
    • Football
    • Basketball
    • Tennis
    • Olympics
    • Motorsport
  • Entertainment
    • Movies
    • Music
    • TV & Streaming
    • Celebrity News
    • Awards & Festivals
  • Crime & Justice
    • Court Cases
    • Cybercrime
    • Policing
    • Criminal Investigations
    • Legal Reforms
No Result
View All Result
  • Home
  • World News
    • Us & Canada
    • Europe
    • Asia
    • Africa
    • Middle East
  • Politics
    • Elections
    • Political Parties
    • Government Policies
    • International Relations
    • Legislative News
  • Business & Finance
    • Market Trends
    • Stock Market
    • Entrepreneurship
    • Corporate News
    • Economic Policies
  • Science & Environment
    • Space Exploration
    • Climate Change
    • Wildlife & Conservation
    • Environmental Policies
    • Medical Research
  • Health
    • Public Health
    • Mental Health
    • Medical Breakthroughs
    • Fitness & Nutrition
    • Pandemic Updates
  • Sports
    • Football
    • Basketball
    • Tennis
    • Olympics
    • Motorsport
  • Entertainment
    • Movies
    • Music
    • TV & Streaming
    • Celebrity News
    • Awards & Festivals
  • Crime & Justice
    • Court Cases
    • Cybercrime
    • Policing
    • Criminal Investigations
    • Legal Reforms
No Result
View All Result
Today Headline
No Result
View All Result
Home Science & Environment Medical Research

Pancreatic cancer RNA vaccine shows durable T cell immunity

February 24, 2025
in Medical Research
Reading Time: 3 mins read
A A
0
vaccine
3
SHARES
7
VIEWS
Share on FacebookShare on Twitter


vaccine
Credit: CC0 Public Domain

Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional CD8+ T cells in patients with pancreatic ductal adenocarcinoma (PDAC), potentially delaying disease recurrence.

PDAC is a lethal cancer with limited treatment options and a low mutational burden. T cells defend the body by destroying harmful outside pathogens and mutated body cells, such as cancer.

Mutations in tumor cells can create neoantigens, novel proteins not present in normal cells. Finding these (via MHC molecules) alerts T cells that the tumor cell is no longer part of the body’s normal self. The low mutational burden of PDAC produces few neoantigens, making tumors difficult for T cells to distinguish from self cells.

Traditional cancer vaccines have struggled to produce durable tumor-specific T cell responses. This study aimed to determine if an RNA neoantigen vaccine could induce long-term functional T cells that correlate with delayed PDAC recurrence.

In the Phase I trial, “RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer,” published in Nature, the team evaluated the effects of autogene cevumeran, an individualized mRNA–lipoplex vaccine encoding up to 20 neoantigens, combined with surgery, atezolizumab, and chemotherapy (mFOLFIRINOX).

Sixteen patients with resectable PDAC received autogene cevumeran following surgery and a single dose of atezolizumab, succeeded by 12 cycles of modified FOLFIRINOX chemotherapy and a vaccine boost. Investigators assessed vaccine-induced T cell responses using ex vivo IFNγ ELISpot assays, T cell receptor (TCR) sequencing, and longitudinal blood and tissue analyses over a median follow-up of 3.2 years.

Eight of the sixteen vaccinated patients developed strong neoantigen-specific CD8+ T cell responses following vaccination. These patients, referred to as responders, experienced fewer cancer recurrences during the study period.

A median time to recurrence for the responders could not be determined since the majority had not relapsed by the study’s end. Highly favorable survival outcomes of the responders were compared to a median of 13.4 months in non-responders.

CloneTrack, a sequencing-based tool, identified 79 vaccine-induced CD8+ T cell clones in responders. Clones induced during priming doses reached peak expansion after six or fewer doses, with an average 100-fold expansion.

Vaccine-induced CD8+ T cell clones demonstrated long-term persistence, with a projected average lifespan of 7.7 years post-boost. 86% of clones persisted at substantial frequencies for ~3 years post-vaccination. Approximately 20% of these clones could persist for decades, potentially outliving the host.

Vaccine-induced T cells transitioned from proliferative to effector states and stabilized as tissue-resident memory-like (TRM-like) cells, retaining cytotoxic functions for years. Persistent CD8+ T cells maintained neoantigen-specific effector function upon in vitro rechallenge, even up to 3.6 years post-vaccination.

Tumors from patients who recurred showed a selective loss of vaccine-targeted cancer clones, indicating the need to address tumor heterogeneity and clonal escape mechanisms.

The potential of adjuvant mRNA–lipoplex neoantigen vaccines to induce durable, functional immunity (after surgery) in one of the most treatment-resistant cancers is clearly established (for a Phase I trial) with potential applications to cancers beyond PDAC.

Larger trials are needed to confirm efficacy and further research on increasing responder rates and reducing clonal escape.

More information:
Zachary Sethna et al, RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer, Nature (2025). DOI: 10.1038/s41586-024-08508-4

Bespoke vaccines can elicit long-lived immune activity against pancreatic cancer, Nature (2025). DOI: 10.1038/d41586-025-00470-z

© 2025 Science X Network

Citation:
Pancreatic cancer RNA vaccine shows durable T cell immunity (2025, February 24)
retrieved 24 February 2025
from https://medicalxpress.com/news/2025-02-pancreatic-cancer-rna-vaccine-durable.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.




vaccine
Credit: CC0 Public Domain

Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional CD8+ T cells in patients with pancreatic ductal adenocarcinoma (PDAC), potentially delaying disease recurrence.

PDAC is a lethal cancer with limited treatment options and a low mutational burden. T cells defend the body by destroying harmful outside pathogens and mutated body cells, such as cancer.

Mutations in tumor cells can create neoantigens, novel proteins not present in normal cells. Finding these (via MHC molecules) alerts T cells that the tumor cell is no longer part of the body’s normal self. The low mutational burden of PDAC produces few neoantigens, making tumors difficult for T cells to distinguish from self cells.

Traditional cancer vaccines have struggled to produce durable tumor-specific T cell responses. This study aimed to determine if an RNA neoantigen vaccine could induce long-term functional T cells that correlate with delayed PDAC recurrence.

In the Phase I trial, “RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer,” published in Nature, the team evaluated the effects of autogene cevumeran, an individualized mRNA–lipoplex vaccine encoding up to 20 neoantigens, combined with surgery, atezolizumab, and chemotherapy (mFOLFIRINOX).

Sixteen patients with resectable PDAC received autogene cevumeran following surgery and a single dose of atezolizumab, succeeded by 12 cycles of modified FOLFIRINOX chemotherapy and a vaccine boost. Investigators assessed vaccine-induced T cell responses using ex vivo IFNγ ELISpot assays, T cell receptor (TCR) sequencing, and longitudinal blood and tissue analyses over a median follow-up of 3.2 years.

Eight of the sixteen vaccinated patients developed strong neoantigen-specific CD8+ T cell responses following vaccination. These patients, referred to as responders, experienced fewer cancer recurrences during the study period.

A median time to recurrence for the responders could not be determined since the majority had not relapsed by the study’s end. Highly favorable survival outcomes of the responders were compared to a median of 13.4 months in non-responders.

CloneTrack, a sequencing-based tool, identified 79 vaccine-induced CD8+ T cell clones in responders. Clones induced during priming doses reached peak expansion after six or fewer doses, with an average 100-fold expansion.

Vaccine-induced CD8+ T cell clones demonstrated long-term persistence, with a projected average lifespan of 7.7 years post-boost. 86% of clones persisted at substantial frequencies for ~3 years post-vaccination. Approximately 20% of these clones could persist for decades, potentially outliving the host.

Vaccine-induced T cells transitioned from proliferative to effector states and stabilized as tissue-resident memory-like (TRM-like) cells, retaining cytotoxic functions for years. Persistent CD8+ T cells maintained neoantigen-specific effector function upon in vitro rechallenge, even up to 3.6 years post-vaccination.

Tumors from patients who recurred showed a selective loss of vaccine-targeted cancer clones, indicating the need to address tumor heterogeneity and clonal escape mechanisms.

The potential of adjuvant mRNA–lipoplex neoantigen vaccines to induce durable, functional immunity (after surgery) in one of the most treatment-resistant cancers is clearly established (for a Phase I trial) with potential applications to cancers beyond PDAC.

Larger trials are needed to confirm efficacy and further research on increasing responder rates and reducing clonal escape.

More information:
Zachary Sethna et al, RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer, Nature (2025). DOI: 10.1038/s41586-024-08508-4

Bespoke vaccines can elicit long-lived immune activity against pancreatic cancer, Nature (2025). DOI: 10.1038/d41586-025-00470-z

© 2025 Science X Network

Citation:
Pancreatic cancer RNA vaccine shows durable T cell immunity (2025, February 24)
retrieved 24 February 2025
from https://medicalxpress.com/news/2025-02-pancreatic-cancer-rna-vaccine-durable.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.



Tags: Health ResearchHealth Research NewsHealth ScienceMedicine ResearchMedicine Research NewsMedicine Science
Previous Post

U.S. in standoff with Ukraine and Europe over competing U.N. resolutions about Russia-Ukraine war

Next Post

NASA Invites Media to Attend Alabama Space Day 2025

Related Posts

Journalists Recap State of NIH Cancer Research and Abortion Law’s Effect on Clinical Decisions

June 7, 2025
2
Measles outbreaks in Michigan and Pennsylvania end, while Texas logs just 4 new cases

Measles outbreaks in Michigan and Pennsylvania end, while Texas logs just 4 new cases

June 7, 2025
0
Next Post

NASA Invites Media to Attend Alabama Space Day 2025

  • Trending
  • Comments
  • Latest
Family calls for change after B.C. nurse dies by suicide after attacks on the job

Family calls for change after B.C. nurse dies by suicide after attacks on the job

April 2, 2025
Pioneering 3D printing project shares successes

Product reduces TPH levels to non-hazardous status

November 27, 2024

Hospital Mergers Fail to Deliver Better Care or Lower Costs, Study Finds todayheadline

December 31, 2024

Police ID man who died after Corso Italia fight

December 23, 2024
Harris tells supporters 'never give up' and urges peaceful transfer of power

Harris tells supporters ‘never give up’ and urges peaceful transfer of power

0
Des Moines Man Accused Of Shooting Ex-Girlfriend's Mother

Des Moines Man Accused Of Shooting Ex-Girlfriend’s Mother

0

Trump ‘looks forward’ to White House meeting with Biden

0
Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

0

Journalists Recap State of NIH Cancer Research and Abortion Law’s Effect on Clinical Decisions

June 7, 2025
Brothers bring boxing back to Fenway after 70 years and hope to revitalize the sport in Boston

Brothers bring boxing back to Fenway after 70 years and hope to revitalize the sport in Boston

June 7, 2025
Trump's big bill also seeks to undo the big bills of Biden and Obama

Trump’s big bill also seeks to undo the big bills of Biden and Obama

June 7, 2025
U.S. with India in fight against terrorism: Deputy Secretary of State tells Indian delegation

U.S. with India in fight against terrorism: Deputy Secretary of State tells Indian delegation

June 7, 2025

Recent News

Journalists Recap State of NIH Cancer Research and Abortion Law’s Effect on Clinical Decisions

June 7, 2025
2
Brothers bring boxing back to Fenway after 70 years and hope to revitalize the sport in Boston

Brothers bring boxing back to Fenway after 70 years and hope to revitalize the sport in Boston

June 7, 2025
5
Trump's big bill also seeks to undo the big bills of Biden and Obama

Trump’s big bill also seeks to undo the big bills of Biden and Obama

June 7, 2025
5
U.S. with India in fight against terrorism: Deputy Secretary of State tells Indian delegation

U.S. with India in fight against terrorism: Deputy Secretary of State tells Indian delegation

June 7, 2025
4

TodayHeadline is a dynamic news website dedicated to delivering up-to-date and comprehensive news coverage from around the globe.

Follow Us

Browse by Category

  • Africa
  • Asia
  • Basketball
  • Business & Finance
  • Climate Change
  • Crime & Justice
  • Cybersecurity
  • Economic Policies
  • Elections
  • Entertainment
  • Entrepreneurship
  • Environmental Policies
  • Europe
  • Football
  • Gadgets & Devices
  • Health
  • Medical Research
  • Mental Health
  • Middle East
  • Motorsport
  • Olympics
  • Politics
  • Public Health
  • Relationships & Family
  • Science & Environment
  • Software & Apps
  • Space Exploration
  • Sports
  • Stock Market
  • Technology & Startups
  • Tennis
  • Travel
  • Uncategorized
  • Us & Canada
  • Wildlife & Conservation
  • World News

Recent News

Journalists Recap State of NIH Cancer Research and Abortion Law’s Effect on Clinical Decisions

June 7, 2025
Brothers bring boxing back to Fenway after 70 years and hope to revitalize the sport in Boston

Brothers bring boxing back to Fenway after 70 years and hope to revitalize the sport in Boston

June 7, 2025
  • Education
  • Lifestyle
  • Technology & Startups
  • About us
  • Contact
  • Advertise with Us
  • Privacy & Policy

© 2024 Todayheadline.co

Welcome Back!

OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Business & Finance
  • Corporate News
  • Economic Policies
  • Entrepreneurship
  • Market Trends
  • Crime & Justice
  • Court Cases
  • Criminal Investigations
  • Cybercrime
  • Legal Reforms
  • Policing
  • Education
  • Higher Education
  • Online Learning
  • Entertainment
  • Awards & Festivals
  • Celebrity News
  • Movies
  • Music
  • Health
  • Fitness & Nutrition
  • Medical Breakthroughs
  • Mental Health
  • Pandemic Updates
  • Lifestyle
  • Fashion & Beauty
  • Food & Drink
  • Home & Living
  • Politics
  • Elections
  • Government Policies
  • International Relations
  • Legislative News
  • Political Parties
  • Africa
  • Asia
  • Europe
  • Middle East
  • Artificial Intelligence
  • Cybersecurity
  • Emerging Technologies
  • Gadgets & Devices
  • Industry Analysis
  • Basketball
  • Football
  • Motorsport
  • Olympics
  • Climate Change
  • Environmental Policies
  • Medical Research
  • Science & Environment
  • Space Exploration
  • Wildlife & Conservation
  • Sports
  • Tennis
  • Technology & Startups
  • Software & Apps
  • Startup Success Stories
  • Startups & Innovations
  • Tech Regulations
  • Venture Capital
  • Uncategorized
  • World News
  • Us & Canada
  • Public Health
  • Relationships & Family
  • Travel
  • Research & Innovation
  • Scholarships & Grants
  • School Reforms
  • Stock Market
  • TV & Streaming
  • Advertise with Us
  • Privacy & Policy
  • About us
  • Contact

© 2024 Todayheadline.co